Findings indicate that regular vitamin D screenings may be beneficial, especially for African- and European-American men.
Browsing: Cancer
Scientists from five institutions, including Northwestern, discovered a cancer-specific biomarker found in all stages of breast, prostate and pancreatic cancers.
Marcus Peter, PhD, professor in Medicine-Hematology/Oncology, has discovered how the removal of a known “tumor suppressor” causes cancer cells to kill themselves.
Northwestern Medicine scientists have developed a new prognostic tool for clinicians treating patients with large B-cell lymphoma. The predictive scale enhances the widely used International Prognostic Index.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has named Deputy Director Leonidas Platanias, MD, PhD, professor of Medicine-Hematology/Oncology, interim director, effective immediately.
Second-year medical student Chaitanya Medicherla explores the effects of immune cells on cancer development as part of his Area of Scholarly Concentration research project.
Research by Seth Corey, MD, MPH, professor in pediatrics-hematology, oncology, and stem cell transplantation and cell and molecular biology, was recently published.
The director of melanoma research within the Northwestern Skin Cancer Institute presented his validation study at a meeting of the American Academy of Dermatology.
Scientists are working to determine if a specific receptor inhibitor could be used to augment chemotherapy or prevent relapse in individuals with the disease.